MRRPhysical AI
intelligence
← Company intelligence

Robot maker · registered

Quantum Surgical

Corporate marketmedicalCurated record
quantumsurgical.com

Epione 6-DOF robotic arm with AI-guided planning for percutaneous tumour ablation; Smart Segmentation tool for rapid 3D tumour delineation from CT/MRI; intra-operative MRI/CT image fusion for enhanced tumour visualisation; real-time respiration and patient-motion tracking during anesthesia; multi-needle oblique trajectory planning for complex tumour geometries; universal needle guide compatible with microwave ablation (MWA), radiofrequency ablation (RFA), cryoablation, irreversible electroporation (IRE), and electrochemotherapy (ECT).

HeadquartersMontpellier, FR
Founded2017
Corporate funding$81M
Team101-200
Deployments7
Open roles0
01

Company overview

Identity and operating footprint

Company typeRobot maker
Market segmentCorporate
StageAcquired
FoundersBertin Nahum (Co-founder & President, Quantum Surgical), Fernand Badano (Co-founder & Managing Director), Lucien Blondel (Co-founder & CTO), Sophie Roca (Co-founder)
Regions servedEurope, North America, Asia-Pacific
Countries deployedFR, GB, US, TW
Service footprintEpione robotic ablation platform at 20+ cancer centres across France, UK, US, and Taiwan; CE marked and FDA cleared; 1,700+ patients treated; HQ Montpellier with Miami, FL office; 130+ employees.
Last reviewed2026-07-05
MX

Robot models

Specifications remain vendor-claimed

Machinemedical

Epione

  • 6 degrees of freedom robotic arm

    Vendor-stated DOF of the needle-positioning robotic arm enabling precise placement at desired location, angle, and depth

    Claim source
  • CE marked for abdomen, chest, and musculoskeletal structures

    Regulatory approval for indicated anatomical targets in European markets; CE mark issued by TÜV Rheinland (Certificate No. HZ 1551912-1)

    Claim source
  • FDA cleared for abdominal ablation procedures

    US FDA clearance for percutaneous abdominal tumour ablation

    Claim source
  • 1,700+ patients treated across 20+ installed cancer centres

    Vendor-stated cumulative clinical patient count as of 2025

    Claim source
DP

Deployment log

Announced and cited only

AnnouncedCustomerSiteCountryCountEvidence
2025-12-05Leeds Teaching Hospitals NHS Trust (GB)NHS hospitalGBNot disclosedAnnouncement
2025-06-10King's College Hospital NHS Foundation Trust (GB)NHS hospitalGBNot disclosedAnnouncement
2025-02-04CHU Toulouse (Toulouse University Hospital)university hospital, percutaneous tumour ablation (STARThu programme)FR1Announcement
2024-03-27Institut Paoli-Calmettescancer centre, percutaneous tumour ablationFR1Announcement
2023-05-24Baptist Health South Florida (Miami, US)cancer treatment hospitalUSNot disclosedAnnouncement
2022-11-01Hospices Civils de Lyon (FR)hospitalFRNot disclosedAnnouncement
2022-01-01Gustave Roussy (Villejuif, FR)cancer treatment hospitalFRNot disclosedAnnouncement
CA

Funding history

Publicly announced rounds

Investors on recordAlly Bridge GroupBpifranceCaisse d'Epargne Languedoc-RoussillonEuropean Investment BankMuhan Investment Company
TL

Company timeline

Milestones and announcements

2026-03-26Taiwan Ministry of Health and Welfare (TMHW) grants market authorization for Epione robotic platformQuantum Surgical
2026-02-24Acquired NeuWave Medical from J&J; Quantum Surgical and NeuWave operate as subsidiaries of newly created Precision IO Group Inc. (CEO: Kurt Azarbarzin); Ally Bridge Group largest investorYahoo Finance
2026-02-03Quantum Surgical joins €23.9M EU PreciseOnco project (Innovative Health Initiative / Horizon Europe) with Philips, IGEA, EIBIR, CIRSE, and five European university hospitalsQuantum Surgical
2025-12-04Leeds Teaching Hospitals NHS Trust (UK) acquires Epione; fastest-adopting centre: 25+ patients in under 10 weeksQuantum Surgical
2025-09-01CE mark expanded to bone tumours and metastases (TÜV Rheinland)Quantum Surgical
2024-03-27€30M EIB loan under InvestEU programme to accelerate worldwide commercialisation of EpioneEuropean Investment Bank
2021-01-01€40M Series A led by Ally Bridge Group (€20M); first EIB loan for commercial launch of EpioneAlly Bridge Group
2017-01-01Quantum Surgical founded in Montpellier by Bertin Nahum and co-founders; team met at Medtech SA (sold to Zimmer Biomet 2016)Quantum Surgical
SC

Source ledger

17 unique public sources

01
Quantum Surgical Announces Acquisition of NeuWave Medical, Inc.Yahoo Finance · retrieved 2026-07-05
02
France: Medical robotics company Quantum Surgical gets EIB loan to advance tumour treatment (€30M loan under InvestEU; original EUR converted at ~$1.083/EUR March 2024)European Investment Bank · retrieved 2026-07-05
03
Quantum Surgical Secures EUR 40 million to Support the Commercial Launch of Epione (approx. USD 48M at Oct 2021 rates)Ally Bridge Group · retrieved 2026-07-05
04
Ally Bridge Group Expands Early-stage Cancer Solution Portfolio with Investment in Quantum Surgical (first tranche; total ABG commitment described as $50M; amount of this tranche undisclosed)PR Newswire · retrieved 2026-07-05
05
Epione Robotic Platform for Percutaneous Tumour AblationQuantum Surgical · retrieved 2026-07-05
06
About Quantum SurgicalQuantum Surgical · retrieved 2026-07-05
07
Leeds Teaching Hospitals NHS Trust Acquires Robotic PlatformQuantum Surgical · retrieved 2026-07-05
08
King's College Hospital Becomes First in United Kingdom to Adopt Robotic Platform for Cancer Tumors in the Abdomen and the LungsBusiness Wire · retrieved 2026-07-05
09
The Toulouse University Hospital (France) Acquires EpioneQuantum Surgical · retrieved 2026-07-05
10
First patient treated in the United States with Quantum Surgical's Epione® robotQuantum Surgical · retrieved 2026-07-05
11
Second Installation of the Epione® RobotQuantum Surgical · retrieved 2026-07-05
12
Gustave Roussy becomes the first center in the world to adopt Epione®Quantum Surgical · retrieved 2026-07-05
13
Quantum Surgical | Robotic-Assisted Cancer Treatment & Tumor Ablation TechnologyQuantum Surgical · retrieved 2026-07-05
14
Quantum Surgical obtained market authorization for Epione in TaiwanQuantum Surgical · retrieved 2026-07-05
15
News: Quantum SurgicalQuantum Surgical · retrieved 2026-07-05
16
Quantum Surgical at the Heart of a €23.9M European Project for Precision Cancer TreatmentQuantum Surgical · retrieved 2026-07-05
17
Quantum Surgical Obtains CE Mark Approval for Bone Tumors and LesionsQuantum Surgical · retrieved 2026-07-05